Zura Bio Limited (ZURA) Balance Sheet
ZURA balance sheet, 2025
December 31, 2025 · U.S. dollars$113.9M assets = $12.4M liabilities + $101.5M equity
Both columns are drawn to the same scale: what ZURA owns equals what it owes plus shareholders’ equity. Hover a block for its value.
ZURA financial health
Descriptive bands, not a rating. Fiscal 2025.
ZURA balance sheet trends, 2021–2025
| Metric | Trend | Then | Latest | Change |
|---|---|---|---|---|
| Total assets | $140.6M2021 | $113.9M2025 | −5.1%/yr | |
| Total liabilities | $10.4M2021 | $12.4M2025 | +4.6%/yr | |
| Shareholders’ equity | $130.2M2021 | $101.5M2025 | −6.0%/yr | |
| Cash & short-term investments | $729,2232021 | $109.4M2025 | +250.0%/yr | |
| Working capital | $879,8252021 | $99.9M2025 | +$99.0M | |
| Book value per share | $1.792023 | $1.082025 | −22.5%/yr | |
| Current ratio | 4.232021 | 9.052025 | +4.82 | |
| Shares outstanding | 33.1M2023 | 94.2M2025 | +68.8%/yr |
Change is the average annual growth (CAGR) or the difference between the first and latest year.
ZURA assets
ZURA liabilities and equity
ZURA debt vs cash
Debt includes short- and long-term borrowings and, where reported, lease obligations.
ZURA balance sheet
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Assets | |||||
| Cash & short-term investments | $109.4M | $176.5M | $99.8M | $1.6M | $729,223 |
| Cash & equivalents | $109.4M | $176.5M | $99.8M | $1.6M | $729,223 |
| Receivables | $0 | $0 | $0 | $0 | $0 |
| Inventory | $0 | $0 | $0 | $0 | $0 |
| Other current assets | $2.9M | $2.2M | $1.0M | $209,000 | $422,894 |
| Total current assets | $112.3M | $178.7M | $100.8M | $1.8M | $1.2M |
| Property, plant & equipment (net) | $126,000 | $91,000 | $0 | $0 | $0 |
| Goodwill & intangible assets | $0 | $0 | $0 | $0 | $0 |
| Long-term investments | $0 | $0 | $0 | $0 | $0 |
| Other non-current assets | $1.5M | $698,000 | $0 | $3.5M | $139.4M |
| Total assets | $113.9M | $179.5M | $100.8M | $5.3M | $140.6M |
| Liabilities | |||||
| Accounts payable | $1.3M | $733,000 | $2.7M | $2.0M | $7,000 |
| Short-term debt | — | — | — | $7.8M | — |
| Deferred revenue | — | — | — | −$355,595 | — |
| Total current liabilities | $12.4M | $19.5M | $20.3M | $14.8M | $272,292 |
| Long-term debt | $0 | $0 | $0 | $0 | $0 |
| Other long-term liabilities | $0 | $0 | $990,000 | $12.5M | $10.1M |
| Total liabilities | $12.4M | $19.5M | $21.3M | $27.3M | $10.4M |
| Shareholders' equity | |||||
| Common stock & paid-in capital | $7,000 | $7,000 | $4,000 | $141.4M | $139.4M |
| Retained earnings (deficit) | −$224.5M | −$155.9M | −$103.5M | −$32.1M | −$9.2M |
| Accumulated other comprehensive income | — | — | — | — | −$278.8M |
| Minority interest | $0 | $13.2M | $20.2M | $10.0M | — |
| Total shareholders' equity | $101.5M | $146.8M | $59.3M | −$32.1M | $130.2M |
| Key figures | |||||
| Total debt | — | — | — | $7.8M | — |
| Net cash (debt) | — | — | — | −$6.2M | — |
| Working capital | $99.9M | $159.2M | $80.5M | −$13.0M | $879,825 |
| Tangible book value | $101.5M | $146.8M | $59.3M | −$32.1M | $130.2M |
| Book value per share | $1.08 | $1.96 | $1.79 | — | — |
| Shares outstanding | 94.2M | 75.1M | 33.1M | — | — |
| Current ratio | 9.05 | 9.16 | 4.97 | 0.12 | 4.23 |
| Quick ratio | 8.82 | 9.04 | 4.92 | 0.11 | 2.68 |
| Equity / assets | 89.1% | 81.8% | 58.8% | −609.2% | 92.6% |
| Jun '26 | Mar '26 | Dec '25 | Sep '25 | Jun '25 | Mar '25 | Dec '24 | Sep '24 | Jun '24 | Mar '24 | Dec '23 | Sep '23 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||||
| Cash & short-term investments | $205.1M | $225.6M | $109.4M | $139.0M | $154.5M | $170.6M | $176.5M | $188.2M | $188.4M | $89.8M | $99.8M | $103.9M |
| Cash & equivalents | $205.1M | $225.6M | $109.4M | $139.0M | $154.5M | $170.6M | $176.5M | $188.2M | $188.4M | $89.8M | $99.8M | $103.9M |
| Receivables | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Inventory | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other current assets | $5.4M | $1.4M | $2.9M | $3.3M | $2.5M | $1.1M | $2.2M | $754,000 | $1.0M | $657,000 | $1.0M | $733,000 |
| Total current assets | $210.5M | $227.0M | $112.3M | $142.3M | $157.0M | $171.7M | $178.7M | $189.0M | $189.5M | $90.5M | $100.8M | $104.6M |
| Property, plant & equipment (net) | $149,000 | $125,000 | $126,000 | $131,000 | $122,000 | $106,000 | $91,000 | $44,000 | $25,000 | $9,000 | $0 | $0 |
| Goodwill & intangible assets | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Long-term investments | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other non-current assets | $2.8M | $1.5M | $1.5M | $1.5M | $698,000 | $698,000 | $698,000 | $52,000 | $0 | $0 | $0 | $0 |
| Total assets | $213.4M | $228.6M | $113.9M | $143.9M | $157.8M | $172.5M | $179.5M | $189.1M | $189.5M | $90.5M | $100.8M | $104.6M |
| Liabilities | ||||||||||||
| Accounts payable | $3.3M | $2.1M | $1.3M | $3.3M | $1.2M | $1.2M | $733,000 | $1.0M | $990,000 | $1.5M | $2.7M | $1.6M |
| Total current liabilities | $16.3M | $11.7M | $12.4M | $25.5M | $18.7M | $21.1M | $19.5M | $18.2M | $15.1M | $14.7M | $20.3M | $17.0M |
| Long-term debt | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other long-term liabilities | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $2.4M | $1.6M | $990,000 | $1.9M |
| Total liabilities | $16.3M | $11.7M | $12.4M | $25.5M | $18.7M | $21.1M | $19.5M | $18.2M | $17.4M | $16.3M | $21.3M | $19.0M |
| Shareholders' equity | ||||||||||||
| Common stock & paid-in capital | $10,000 | $9,000 | $7,000 | $7,000 | $7,000 | $7,000 | $7,000 | $7,000 | $6,000 | $4,000 | $4,000 | $4,000 |
| Retained earnings (deficit) | −$275.1M | −$248.8M | −$224.5M | −$207.4M | −$189.3M | −$173.3M | −$155.9M | −$142.3M | −$121.6M | −$111.2M | −$103.5M | −$95.0M |
| Minority interest | $0 | $0 | $0 | $10.2M | $13.2M | — | — | — | — | — | — | — |
| Total shareholders' equity | $197.1M | $216.9M | $101.5M | $108.2M | $125.9M | $138.2M | $146.8M | $153.0M | $156.5M | $61.0M | $59.3M | $63.2M |
| Key figures | ||||||||||||
| Working capital | $194.2M | $215.3M | $99.9M | $116.8M | $138.3M | $150.6M | $159.2M | $170.7M | $174.4M | $75.8M | $80.5M | $87.6M |
| Tangible book value | $197.1M | $216.9M | $101.5M | $108.2M | $125.9M | $138.2M | $146.8M | $153.0M | $156.5M | $61.0M | $59.3M | $63.2M |
| Book value per share | $1.55 | $1.93 | $1.08 | $1.14 | $1.34 | $2.12 | $2.25 | $1.75 | $2.09 | $1.30 | $1.26 | $1.35 |
| Shares outstanding | 126.8M | 112.2M | 94.2M | 94.6M | 94.3M | 65.3M | 65.3M | 87.3M | 74.9M | 46.9M | 47.0M | 46.9M |
| Current ratio | 12.90 | 19.33 | 9.05 | 5.58 | 8.40 | 8.14 | 9.16 | 10.36 | 12.57 | 6.17 | 4.97 | 6.15 |
| Quick ratio | 12.57 | 19.21 | 8.82 | 5.45 | 8.26 | 8.09 | 9.04 | 10.32 | 12.50 | 6.12 | 4.92 | 6.11 |
| Equity / assets | 92.4% | 94.9% | 89.1% | 75.2% | 79.8% | 80.1% | 81.8% | 80.9% | 82.6% | 67.4% | 58.8% | 60.4% |
Quarterly columns are labeled by the month the quarter ended. Figures in U.S. dollars as reported (latest annual report filed March 19, 2026); data from EODHD.
ZURA financial position
At the end of fiscal 2025 (December 31, 2025), Zura Bio had total assets of $113.9 million (down 36.5% from a year earlier), total liabilities of $12.4 million and shareholders' equity of $101.5 million. Its current ratio was 9.05. In the latest quarter (ended June 30, 2026) total assets were $213.4 million and equity $197.1 million.
Related: ZURA income statement, ZURA cash flow statement, ZURA key metrics. See the ZURA stock overview for the latest quote and news.
ZURA balance sheet FAQ
What are Zura Bio's total assets?
Zura Bio reported total assets of $113.9 million at the end of fiscal 2025 (December 31, 2025), compared with $179.5 million a year earlier.
How much cash does Zura Bio have?
Zura Bio held $109.4 million in cash and short-term investments at the end of fiscal 2025.
What is Zura Bio's book value?
Zura Bio's shareholders' equity (book value) was $101.5 million at the end of fiscal 2025, or $1.08 per share.
What is Zura Bio's current ratio?
Zura Bio had current assets of $112.3 million and current liabilities of $12.4 million, a current ratio of 9.05 (it can cover its short-term obligations).